T cell-specific overexpression of TGFß1 fails to influence atherosclerosis in apoe-deficient mice

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Reifenberg, Kurt ^a   Cheng, Fei ^b   Twardowski, Laura ^c   Küpper, Ines ^b   Wiese, Elena ^b   Bollmann, Franziska ^b   Kleinert, Hartmut ^b   Blessing, Manfred ^d   Lackner, Karl J ^b   Torzewski, Michael ^b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CD3 ANTIGEN; COLLAGEN; TRANSFORMING GROWTH FACTOR BETA1; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; ANIMAL; BLOOD; DEFICIENCY; DISEASE COURSE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; LIPOPROTEINS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84891933486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081444     Document Type: Article

References (45)

1. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358. (Pubitemid 30408720)
2. Massague J, Blain SW, Lo RS (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
3. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, et al. (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90:770-774. (Pubitemid 23028947)
4. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
5. Bobik A (2006) Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 26:1712-1720. (Pubitemid 44305323)
6. Bjorkerud S (1991) Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb 11:892-902.
7. Owens GK, Geisterfer AA, Yang YW, Komoriya A (1988) Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107:771-780.
8. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, et al. (1995) The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1:74-79.
9. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, et al. (1999) Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19:2355-2363. (Pubitemid 29477836)
10. Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K (2002) Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis 13:139-143. (Pubitemid 34747960)
11. Mallat Z, Tedgui A (2001) Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 88:998-1003. (Pubitemid 34137111)
12. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, et al. (2002) Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22:975-982. (Pubitemid 34655226)
13. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, et al. (2009) TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 29:1251-1257.
14. Reifenberg K, Cheng F, Orning C, Crain J, Kupper I, et al. (2012) Overexpression of TGF-ss1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice. PLoS One 7:e40990.
15. Ketelhuth DF, Hansson GK (2011) Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb Haemost 106:779-786.
16. Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, et al. (2003) Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102:4052-4058. (Pubitemid 37486988)
17. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, et al. (2003) Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 112:1342-1350. (Pubitemid 38057688)
18. Li MO, Sanjabi S, Flavell RA (2006) Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T celldependent and -independent mechanisms. Immunity 25(3):455-471. (Pubitemid 44354214)
19. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, et al. (2003) Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 112:1342-1350. (Pubitemid 38057688)
20. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, et al. (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 transsignaling. Immunity 21:491-501. (Pubitemid 39370505)
21. Schramm C, Huber S, Protschka M, Czochra P, Burg J, et al. (2004) TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int Immunol 16:1241-1249. (Pubitemid 39220423)
22. Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, et al. (2005) IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 4:217-220. (Pubitemid 41365319)
23. Presser K, Schwinge D, Wegmann M, Huber S, Schmitt S, et al. (2008) Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity. J Immunol 181:7751-7758.
24. Sharples K, Plowman GD, Rose TM, Twardzik DR, Purchio AF (1987) Cloning and sequence analysis of simian transforming growth factor-beta cDNA. DNA 6:239-244. (Pubitemid 17117194)
25. Zhumabekov T, Corbella P, Tolaini M, Kioussis D (1995) Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J Immunol Methods 185:133-140.
26. Petkov PM, Ding Y, Cassell MA, Zhang W, Wagner G, et al. (2004) An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res 14:1806-1811. (Pubitemid 39276438)
27. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200-203. (Pubitemid 28325976)
28. Torzewski M, Ochsenhirt V, Kleschyov AL, Oelze M, Daiber A, et al. (2007) Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 27:850-857. (Pubitemid 46606716)
29. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM (1997) Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45:1559-1565. (Pubitemid 27465476)
30. Lehr HA, van der Loos CM, Teeling P, Gown AM (1999) Complete chromogen separation and analysis in double immunohistochemical stains using Photoshopbased image analysis. J Histochem Cytochem 47:119-126.
31. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC (1995) Release and activation of platelet latent TGF-beta in blood clots during dissolution withplasmin. Nat Med 1:932-937.
32. Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K (2002) Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis 13:139-143. (Pubitemid 34747960)
33. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamaté C, et al. (2001) Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89:930-934. (Pubitemid 34627899)
34. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, et al. (2002) Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22:975-982. (Pubitemid 34655226)
35. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, et al. (2009) TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 29:1251-1257.
36. Hansson J, Munn M, Rupp WD, Kahn R, Wood RD (1989) Localization of DNA repair synthesis by human cell extracts to a short region at the site of a lesion. J Biol Chem 264(36):21788-21792. (Pubitemid 20028748)
37. Wan YY, Flavell RA (2007) 'Yin-Yang' functions of transforming growth factorbeta and T regulatory cells in immune regulation. Immunol Re 220:199-213. (Pubitemid 350064011)
38. Klingenberg R, Hansson GK (2009) Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 30:2838-2844.
39. Zhou X, Paulsson G, Stemme S, Hansson GK (1998) Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 101:1717-1725. (Pubitemid 28198502)
40. Song L, Leung C, Schindler C (2001) Lymphocytes are important in early atherosclerosis. J Clin Invest 108:251-259. (Pubitemid 32656249)
41. Dansky HM, Charlton SA, Harper MM, Smith JD (1997) T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A 94:4642-4646. (Pubitemid 27194296)
42. Daugherty A, Pure E, Delfel-Butteiger D, Chen S, Leferovich J, et al. (1997) The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice. J Clin Invest 100:1575-1580. (Pubitemid 27425785)
43. Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F (2013) Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. Thromb Haemost 109:5.
44. Campbell KA, Lipinski MJ, Doran AC, Skaflen MD, Fuster V, et al. (2012) Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res 110:889-900.
45. Zhou X, Stemme S, Hansson GK (1996) Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E- deficient mice. Am J Pathol 149:359-366. (Pubitemid 26256325)